Forming Meaningful PharmaAcademia Partnerships
In large pharma, investment in R&D is increasingly expensive. In academia, there is pressure to produce high-profile science for the improvement...
Source: pharmaceuticalonline.com
Stay updated with breaking news from Door Collaborative Enterprises. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In large pharma, investment in R&D is increasingly expensive. In academia, there is pressure to produce high-profile science for the improvement...